BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18565502)

  • 1. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
    Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
    Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
    Wang R; Yan H; Tang XC
    Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
    Zhang HY; Tang XC
    Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
    Wang R; Tang XC
    Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease.
    Ma X; Gang DR
    Phytochemistry; 2008 Jul; 69(10):2022-8. PubMed ID: 18538805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huperzine A from Huperzia species--an ethnopharmacolgical review.
    Ma X; Tan C; Zhu D; Gang DR; Xiao P
    J Ethnopharmacol; 2007 Aug; 113(1):15-34. PubMed ID: 17644292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huperzine A protects isolated rat brain mitochondria against beta-amyloid peptide.
    Gao X; Zheng CY; Yang L; Tang XC; Zhang HY
    Free Radic Biol Med; 2009 Jun; 46(11):1454-62. PubMed ID: 19272446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of huperzine a in the treatment of Alzheimer's disease.
    Desilets AR; Gickas JJ; Dunican KC
    Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
    Friedli MJ; Inestrosa NC
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.
    Tang XC
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):481-4. PubMed ID: 9863136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.
    Tao Y; Fang L; Yang Y; Jiang H; Yang H; Zhang H; Zhou H
    Proteomics; 2013 Apr; 13(8):1314-24. PubMed ID: 23424162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
    Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
    J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
    Zhang HY; Yan H; Tang XC
    Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
    Wang Y; Tang XC; Zhang HY
    J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
    Patocka J
    Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?
    Qian ZM; Ke Y
    Front Aging Neurosci; 2014; 6():216. PubMed ID: 25191267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lycopodium alkaloids.
    Ma X; Gang DR
    Nat Prod Rep; 2004 Dec; 21(6):752-72. PubMed ID: 15565253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of huperzine A and other Lycopodium alkaloids in Huperzia species grown under controlled conditions and in vitro.
    Ishiuchi K; Park JJ; Long RM; Gang DR
    Phytochemistry; 2013 Jul; 91():208-19. PubMed ID: 23306162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.